Therefore, by increasing ACSL4 expression and the rate of lipid peroxidation, RB1 loss raises the extent that cancer cells depend on GPX4 to block ferroptosis and, on the other hand, sensitizes cancer cells to GPX4 inhibitors or, in general, ferroptosis inducers. This evidence concerns the gene RB1 and cancer.